1. Additional file 2 of Guadecitabine increases response to combined anti-CTLA-4 and anti-PD-1 treatment in mouse melanoma in vivo by controlling T-cells, myeloid derived suppressor and NK cells
- Author
-
Amaro, Adriana, Reggiani, Francesco, Fenoglio, Daniela, Gangemi, Rosaria, Tosi, Anna, Parodi, Alessia, Banelli, Barbara, Rigo, Valentina, Mastracci, Luca, Grillo, Federica, Cereghetti, Alessandra, Tastanova, Aizhan, Ghosh, Adhideb, Sallustio, Fabio, Emionite, Laura, Daga, Antonio, Altosole, Tiziana, Filaci, Gilberto, Rosato, Antonio, Levesque, Mitchell, Maio, Michele, Pfeffer, Ulrich, and Croce, Michela
- Abstract
Additional file 2: Supplementary Figure 2. Gating strategies. A: T cells: tumor infiltrating leukocytes were gated based on SSC-A versus FSC-A and singlets were selected from the FSC-A versus FSC-H dot plot. Dead cells were excluded with Fixable Viability Dye (FVD). On viable cells, CD45+ cells were selected and within this population CD3+T cells. From CD3+ cells CD8+ and CD4+ were differentiated. B: tumor infiltrating leukocytes were gated based on SSC-A versus FSC-A and singlets were selected from the FSC-A versus FSC-H dot plot. Dead cells were excluded with Fixable Viability Dye (FVD). On viable cells, CD45+ cells were selected and among CD45+ cells we studied CD11b+ cells. Representative dot plot of MDSC cell subset: monocytic- (Ly6C+Ly6G-) or granulocytic- (Ly6ClowLy6G+). C: dot plot of myeloid sub population selected on singlet, viable, CD45+ cells as I-Ab-CD11c-/+. Monocytes: Ly6C+Ly6G-, neutrophils: Ly6G+Ly6C+ and macrophages: Ly6C-Ly6G-. On macrophage cell population we analyzed M1/M2 polarization (M1: CD38+Egr2-, M2: CD38-Egr2+).
- Published
- 2023
- Full Text
- View/download PDF